Trials / Completed
CompletedNCT02888496
Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica
Caractérisation Des Anomalies Immunologiques au Cours de la Pseudopolyarthrite rhizomélique et Effets du Traitement Par Tocilizumab
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
Pathophysiology of polymyalgia rheumatica (PMR) is ill defined. This study aims at characterizing immunological abnormalities in PMR patients, and to assess the effects of tocilizumab therapy on this abnormalities.
Detailed description
Comparison of PMR patients and matched control subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tocilizumab | 3 monthly IV infusions in PMR patients |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2016-09-05
- Last updated
- 2016-09-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02888496. Inclusion in this directory is not an endorsement.